About Limulus Bio
Limulus Bio was founded in 2020 and is based in Stockholm, Sweden. Operations focus on the medical device sector, where risk assessment, biological evaluation, and consulting services are delivered to manufacturers. These services support compliance and safety evaluations for medical devices. The company is led by CEO Elisabeth Liljensten, with expertise centered on regulatory and biological aspects of device development.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Limulus Bio
Detailed funding history for Limulus Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Limulus Bio
Limulus Bio has secured backing from 1 investor. Prominent investors backing the company include Veranex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Veranex is recognized as an Innovation CRO specializing in medical device and diagnostic development.
|
Locked | Locked | Locked |
Investor details for Limulus Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Limulus Bio
Investment portfolio details for Limulus Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Limulus Bio
Detailed financials for Limulus Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Limulus Bio Comparisons
Peer comparison for Limulus Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Limulus Bio
Detailed competitors of Limulus Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Limulus Bio
Complete news archive for Limulus Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Limulus Bio
Limulus Bio was founded in 2020.
Limulus Bio is headquartered in Stockholm, Sweden.
Elisabeth Liljensten is the current CEO of Limulus Bio.
Limulus Bio was founded in 2020 and is based in Stockholm, Sweden. Operations focus on the medical device sector, where risk assessment, biological evaluation, and consulting services are delivered to manufacturers. These services support compliance and safety evaluations for medical devices. The company is led by CEO Elisabeth Liljensten, with expertise centered on regulatory and biological aspects of device development.
Limulus Bio has 1 investor. Key investors include Veranex.